Evolutionary Genomics, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2018
November 15, 2018 at 03:31 am IST
Share
Evolutionary Genomics, Inc. announced earnings results for the third quarter ended September 30, 2018. For the third quarter, the company announced net loss was USD 265,299 compared to USD 253,201 a year ago. Basic loss per share was USD 0.06 compared to USD 0.05 a year ago.
For the nine months, net loss was USD 913,411 compared to USD 1.055 million a year ago. Basic loss per share was USD 0.19 compared to USD 0.21 a year ago.
Evolutionary Genomics, Inc. is a genomics research and development company. The Company is focused on the identification and validation of genes that impact commercially traits in crops for the agriculture industry. It uses the Adapted Traits Platform (ATP) to identify commercially valuable genes that control important traits in animals and plants. Its platform identifies genes that have changed successfully to impart new or improved traits. The Company has applied its ATP in research projects, including identifying genes responsible for increases in yield in corn, increases in yield in rice, drought tolerance and sugar content in tomatoes and pest/disease resistance in soybeans, cassava, beans, tomatoes, and cotton. The Company uses ATP to perform throughput molecular evolution analysis to identify positively selected genes based on non-synonymous site (Ka) and synonymous site (Ks) analysis.
EVOLUTIONARY GENOMICS, INC. 
